查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1452712

全球心血管手术设备市场、规模、占有率、预测（2024-2032）、产业趋势、成长、考量、主要公司分析

Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry Trends, Growth, Insight, Top Companies Analysis
出版日期: | 出版商: Renub Research | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

预计2032年，全球心血管手术设备市场规模将达27.7亿美元。 近年来，心血管手术设备因其对患者治疗的重大影响而受到医疗界的关注。 这些设备提供了解决许多心血管疾病的现代解决方案，从微创过程到精细的外科手术。 其准确性、有效性以及缩短患者復原时间的能力吸引了世界各地医疗保健专业人员的注意。 此外，技术进步提高了这些设备的保护和性能，使它们对寻求现代心血管医学顶级结果的医生和患者越来越有吸引力。

2024年至2032年，心血管手术器械的市场规模预计将以3.46%的复合年增长率成长。

心臟病、糖尿病和生活方式相关疾病的迅速增加极大地促进了心臟手术设备市场的成长。 据世界卫生组织 (WHO) 称，心血管疾病 (CVD) 是全球头号死亡原因，每年夺走约 1,790 万人的生命。 超过五分之四的 CVD 相关死亡是由于心臟病发作和中风造成的，其中三分之一发生在 70 岁之前。 心臟病和中风的主要行为风险包括不良营养模式、缺乏体力活动、吸烟和过量饮酒。

在过去的十年中，心臟设备技术的进步及其警讯推动了心血管手术设备市场的发展。 改良的技术可以带来更好的患者治疗效果、更短的復原时间和更高的满意度。 人工智慧就是这样一种技术，它将透过提供先进的监测功能来极大地增强心臟病学。 例如，2023年，Eko推出了SENSORA(TM)心臟病检测平台。 该平台使用人工智慧来检测结构性杂音并帮助诊断瓣膜性心臟病。 扩展的工具指标扩大了解决各种心血管问题的范围，推动市场成长和采用。 因此，2023年心血管手术设备市场规模将达20.4亿美元。

对发展中市场对心血管手术设备不断增长的需求的反应也有助于市场扩张。 例如，雅培于 2022 年推出了现代技术的经导管主动脉瓣植入 (TAVI) 设备 Navitor，增加了印度高风险主动脉瓣狭窄患者获得微创治疗的机会。 主动脉瓣狭窄是一种常见且严重的冠状动脉瓣膜疾病，可能没有症状。 然而，根据美国国立卫生研究院 (NIH) 的数据，印度每 1000 人中就有 4.54 人患有这种疾病。

此外，监管机构对创新产品的批准激增正在广泛推动市场成长。 此外，产品发布、批准、策略性收购和改进是心血管手术设备市场参与者维持和扩大其全球影响力所采用的关键企业技术。 例如，2023 年，雅培(Abbott) 与心血管系统公司(Cardioangio Systems, Inc.) 签署了一项最终协议，雅培(Abbott) 收购CSI，一家以用于解决外周和动脉疾病的创新斑块切除机而闻名的医疗器材公司。 透过此次收购，雅培预计将利用 CSI 的补充技术来扩大其主要血管设备的产品组合。

心律不整在心血管手术设备市场中扮演重要角色。

根据应用，心血管手术设备市场分为先天性心臟病、心律不整、冠状动脉疾病、充血性心臟衰竭等。 由于心律不整的普遍性和危及生命的影响，心律不整在心血管手术器械市场中至关重要。 这刺激了对起搏器和导管消融结构等现代解决方案的需求。 例如，波士顿科学公司(Boston Scientific Corporation) 的FARAPULSE™ 脉衝场消融(PFA) 系统于2024 年获得FDA 批准，这是一种治疗药物难治性、復发性、症状性和阵发性心房颤动的独特技术。

本报告研究了全球心血管手术设备市场，并对市场动态、细分市场、地区和公司进行了全面分析。

目录

第一章简介

第二章研究方法

第 3 章执行摘要

第 4 章市场动态

  • 生长促进因素
  • 作业

第五章心血管手术设备市场

第六章市占率-心血管手术设备市场

  • 依产品类型
  • 依用途
  • 依最终用户
  • 依国家/地区

第七章产品类型-心血管手术设备市场

  • 心跳手术系统
  • 心肺机
  • 心臟消融设备
  • 一次性灌溉用品

第8章应用-心血管手术设备市场

  • 先天性心臟病
  • 心律不整
  • 冠状动脉疾病
  • 充血性心臟衰竭
  • 其他

第 9 章最终使用者 - 心血管手术设备市场

  • 医院
  • 门诊手术中心
  • 其他

第10章国家-心血管手术设备市场

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 比利时
    • 荷兰
    • 土耳其
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 泰国
    • 马来西亚
    • 印尼
    • 澳大利亚
    • 纽西兰
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第 11 章波特五力分析 - 心臟手术设备市场

第十二章 SWOT 分析 - 心臟手术设备市场

第十三章主要公司分析

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Cardinal Health Inc.
  • Medtronic PLC
  • GE Healthcare
  • LivaNova PLC
  • Terumo Corporation

Cardiovascular Surgical Devices Market is predicted to reach US$ 2.77 Billion by 2032, according to Renub Research. Lately, cardiovascular surgical gadgets have received prominence inside the healthcare sector thanks to their large impact on affected person remedy. These devices give modern solutions for addressing numerous cardiovascular illnesses, spanning from minimally invasive processes to elaborate surgical procedures. Their precision, effectiveness, and ability to shorten affected person restoration durations have captured the interest of healthcare specialists globally. Moreover, technological progressions have improved the protection and performance of these devices, rendering them increasingly attractive to both practitioners and sufferers looking for top-rated consequences in contemporary cardiovascular healthcare.

Cardiovascular Surgical Devices Market is anticipated to increase at a CAGR of 3.46% from 2024 to 2032

The surge in cardiac illnesses, diabetes, and lifestyle disorders contributes considerably to the growth of the cardiac surgical devices market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the primary global reason of mortality, claiming approximately 17.9 million lives yearly. Over four-fifths of CVD-related deaths stem from heart attacks and strokes, with a third occurring prematurely in individuals under 70. Key behavioral risk elements for heart sickness and stroke encompass harmful nutritional patterns, a loss of physical activity, tobacco consumption, and excessive alcohol consumption.

Over the past decade, improvements in cardiac device technologies and their warning signs have propelled the cardiovascular surgical devices market. Improved technology yields higher patient outcomes, shorter recovery instances, and higher satisfaction rates. Artificial intelligence is one such technology that substantially enhances cardiology by imparting advanced monitoring abilities. For example, in 2023, Eko launched the SENSORA(TM) Cardiac Disease Detection Platform, which uses AI to detect structural murmurs, aiding in valvular heart disorder diagnosis. Expanded tool indicators widen their scope in addressing diverse cardiovascular issues, fostering market growth and adoption. Hence, the Cardiovascular Surgical Devices Market was worth US$ 2.04 Billion in 2023.

The reaction to heightened demands for cardiovascular surgical devices in developing nations also contributed to the market boom. For instance, in 2022, Abbott launched its contemporary-technology transcatheter aortic valve implantation (TAVI) device, Navitor, which increased access to minimally invasive remedies for intense aortic stenosis patients in India at excessive or intense surgical danger. Aortic stenosis, a general and severe coronary heart valve disorder, frequently lacks considerable signs. However, 4.54 per thousand individuals in India suffer from this condition, according to the National Institutes of Health (NIH).

Moreover, the surge in approvals from the regulatory authorities for groundbreaking products extensively drives the market's growth. Also, product launches, approvals, strategic acquisitions, and improvements are vital enterprise techniques employed by cardiovascular surgical devices market participants to maintain and expand their worldwide presence. For example, in 2023, Abbott and Cardiovascular Systems, Inc. disclosed a definitive agreement for Abbott to gather CSI, a medical device corporation famous for its revolutionary atherectomy machine used in addressing peripheral and artery disease. This acquisition will augment Abbott's leading vascular device portfolio with complementary technologies from CSI.

Cardiac arrhythmia plays a crucial role in the market for cardiovascular surgical devices

Based on Application, the Cardiovascular Surgical Devices Market is categorized into Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, and Others. Cardiac arrhythmia is pivotal in the cardiovascular surgical devices market because of its prevalence and life-threatening implications. This spurs demand for modern solutions like pacemakers and catheter ablation structures. For instance, in 2024, Boston Scientific Corporation received FDA approval for the FARAPULSE(TM) Pulsed Field Ablation (PFA) System, offering a unique technique for treating drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.

China significantly influences the market for cardiovascular surgical devices

The Cardiovascular Surgical Devices Market is split by country, including North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). China is important in the cardiovascular surgical devices market. This is due to its vast population, rising cardiovascular disorder rates, expanding healthcare infrastructure, increasing healthcare expenditure, and developing need for superior scientific technologies. For instance, in July 2022, China's National Medical Products Administration permitted an artificial coronary heart for excessive heart failure created by the China Academy of Launch Vehicle Technology and TEDA International Cardiovascular Hospital.

Key Players

The Cardiovascular Surgical Devices Market includes companies such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC, GE Healthcare, LivaNova PLC, and Terumo Corporation.

Product Type - Market breakup in 4 viewpoints:

1. Beating Heart Surgery Systems

2. Cardiopulmonary Bypass Equipment

3. Cardiac Ablation Devices

4. Perfusion Disposable

Application - Market breakup in 5 viewpoints:

1. Congenital Heart Defects

2. Cardiac Arrhythmia

3. Coronary Heart Disease

4. Congestive Heart Failure

5. Others

End-User - Market breakup in 3 viewpoints:

1. Hospitals

2. Ambulatory Surgical Centers

3. Others

Country - Market of 25 Countries Covered in the Report:

1. North America

  • 1.1 United States
  • 1.2 Canada

2. Europe

  • 2.1 France
  • 2.2 Germany
  • 2.3 Italy
  • 2.4 Spain
  • 2.5 United Kingdom
  • 2.6 Belgium
  • 2.7 Netherland
  • 2.8 Turkey

3. Asia Pacific

  • 3.1 China
  • 3.2 Japan
  • 3.3 India
  • 3.4 South Korea
  • 3.5 Thailand
  • 3.6 Malaysia
  • 3.7 Indonesia
  • 3.8 Australia
  • 3.9 New Zealand

4. Latin America

  • 4.1 Brazil
  • 4.2 Mexico
  • 4.3 Argentina

5. Middle East & Africa

  • 5.1 Saudi Arabia
  • 5.2 UAE
  • 5.3 South Africa

All the Key players have been covered from 3 Viewpoints:

  • Overview
  • Recent Development
  • Revenue Analysis

Company Analysis:

1. Abbott Laboratories

2. Boston Scientific Corporation

3. Edwards Lifesciences

4. Cardinal Health Inc.

5. Medtronic PLC

6. GE Healthcare

7. LivaNova PLC

8. Terumo Corporation

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Cardiovascular Surgical Devices Market

6. Market Share - Cardiovascular Surgical Devices Market

  • 6.1 By Product Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Product Type - Cardiovascular Surgical Devices Market

  • 7.1 Beating Heart Surgery Systems
  • 7.2 Cardiopulmonary Bypass Equipment
  • 7.3 Cardiac Ablation Devices
  • 7.4 Perfusion Disposable

8. Application - Cardiovascular Surgical Devices Market

  • 8.1 Congential Heart Defects
  • 8.2 Cardiac Arrthymia
  • 8.3 Coronary Heart Disease
  • 8.4 Congestive Heart Failure
  • 8.5 Others

9. End User - Cardiovascular Surgical Devices Market

  • 9.1 Hospitals
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Others

10. Countries - Cardiovascular Surgical Devices Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherland
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Thailand
    • 10.3.6 Malaysia
    • 10.3.7 Indonesia
    • 10.3.8 Australia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 Saudi Arabia
    • 10.5.2 UAE
    • 10.5.3 South Africa

11. Porter's Five Forces Analysis - Cardiac Surgery Devices Market

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis - Cardiac Surgery Devices Market

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Key Players Analysis

  • 13.1 Abbott Laboratories
    • 13.1.1 Overview
    • 13.1.2 Recent Development
    • 13.1.3 Revenue Analysis
  • 13.2 Boston Scientific Corporation
    • 13.2.1 Overview
    • 13.2.2 Recent Development
    • 13.2.3 Revenue Analysis
  • 13.3 Edwards Lifesciences
    • 13.3.1 Overview
    • 13.3.2 Recent Development
    • 13.3.3 Revenue Analysis
  • 13.4 Cardinal Health Inc.
    • 13.4.1 Overview
    • 13.4.2 Recent Development
    • 13.4.3 Revenue Analysis
  • 13.5 Medtronic PLC
    • 13.5.1 Overview
    • 13.5.2 Recent Development
    • 13.5.3 Revenue Analysis
  • 13.6 GE Healthcare
    • 13.6.1 Overview
    • 13.6.2 Recent Development
    • 13.6.3 Revenue Analysis
  • 13.7 LivaNova PLC
    • 13.7.1 Overview
    • 13.7.2 Recent Development
    • 13.7.3 Revenue Analysis
  • 13.8 Terumo Corporation
    • 13.8.1 Overview
    • 13.8.2 Recent Development
    • 13.8.3 Revenue Analysis

List of Figures

  • Figure-01: Global - Cardiovascular Surgical Devices Market (Billion US$), 2019 - 2023
  • Figure-02: Global - Forecast for Cardiovascular Surgical Devices Market (Billion US$), 2024 - 2032
  • Figure-03: Product Type - Beating Heart Surgery Systems Market (Million US$), 2019 - 2023
  • Figure-04: Product Type - Forecast for Beating Heart Surgery Systems Market (Million US$), 2024 - 2032
  • Figure-05: Product Type - Cardiopulmonary Bypass Equipment Market (Million US$), 2019 - 2023
  • Figure-06: Product Type - Forecast for Cardiopulmonary Bypass Equipment Market (Million US$), 2024 - 2032
  • Figure-07: Product Type - Cardiac Ablation Devices Market (Million US$), 2019 - 2023
  • Figure-08: Product Type - Forecast for Cardiac Ablation Devices Market (Million US$), 2024 - 2032
  • Figure-09: Product Type - Perfusion Disposable Market (Million US$), 2019 - 2023
  • Figure-10: Product Type - Forecast for Perfusion Disposable Market (Million US$), 2024 - 2032
  • Figure-11: Application - Congential Heart Defects Market (Million US$), 2019 - 2023
  • Figure-12: Application - Forecast for Congential Heart Defects Market (Million US$), 2024 - 2032
  • Figure-13: Application - Cardiac Arrthymia Market (Million US$), 2019 - 2023
  • Figure-14: Application - Forecast for Cardiac Arrthymia Market (Million US$), 2024 - 2032
  • Figure-15: Application - Coronary Heart Disease Market (Million US$), 2019 - 2023
  • Figure-16: Application - Forecast for Coronary Heart Disease Market (Million US$), 2024 - 2032
  • Figure-17: Application - Congestive Heart Failure Market (Million US$), 2019 - 2023
  • Figure-18: Application - Forecast for Congestive Heart Failure Market (Million US$), 2024 - 2032
  • Figure-19: Application - Others Market (Million US$), 2019 - 2023
  • Figure-20: Application - Forecast for Others Market (Million US$), 2024 - 2032
  • Figure-21: End User - Hospitals Market (Million US$), 2019 - 2023
  • Figure-22: End User - Forecast for Hospitals Market (Million US$), 2024 - 2032
  • Figure-23: End User - Ambulatory Surgical Centers Market (Million US$), 2019 - 2023
  • Figure-24: End User - Forecast for Ambulatory Surgical Centers Market (Million US$), 2024 - 2032
  • Figure-25: End User - Others Market (Million US$), 2019 - 2023
  • Figure-26: End User - Forecast for Others Market (Million US$), 2024 - 2032
  • Figure-27: United States - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-28: United States - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-29: Canada - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-30: Canada - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-31: France - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-32: France - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-33: Germany - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-34: Germany - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-35: Italy - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-36: Italy - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-37: Spain - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-38: Spain - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-39: United Kingdom - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-40: United Kingdom - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-41: Belgium - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-42: Belgium - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-43: Netherland - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-44: Netherland - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-45: Turkey - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-46: Turkey - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-47: China - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-48: China - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-49: Japan - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-50: Japan - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-51: India - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-52: India - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-53: South Korea - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-54: South Korea - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-55: Thailand - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-56: Thailand - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-57: Malaysia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-58: Malaysia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-59: Indonesia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-60: Indonesia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-61: Australia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-62: Australia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-63: New Zealand - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-64: New Zealand - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-65: Brazil - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-66: Brazil - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-67: Mexico - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-68: Mexico - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-69: Argentina - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-70: Argentina - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-71: Saudi Arabia - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-72: Saudi Arabia - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-73: UAE - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-74: UAE - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-75: South Africa - Cardiovascular Surgical Devices Market (Million US$), 2019 - 2023
  • Figure-76: South Africa - Forecast for Cardiovascular Surgical Devices Market (Million US$), 2024 - 2032
  • Figure-77: Abbott Laboratories - Global Revenue (Million US$), 2019 - 2023
  • Figure-78: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-79: Boston Scientific Corporation - Global Revenue (Million US$), 2019 - 2023
  • Figure-80: Boston Scientific Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-81: Edwards Lifesciences - Global Revenue (Million US$), 2019 - 2023
  • Figure-82: Edwards Lifesciences - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-83: Cardinal Health Inc. - Global Revenue (Million US$), 2019 - 2023
  • Figure-84: Cardinal Health Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-85: Medtronic PLC - Global Revenue (Million US$), 2019 - 2023
  • Figure-86: Medtronic PLC - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-87: GE Healthcare - Global Revenue (Million US$), 2019 - 2023
  • Figure-88: GE Healthcare - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-89: LivaNova PLC - Global Revenue (Million US$), 2019 - 2023
  • Figure-90: LivaNova PLC - Forecast for Global Revenue (Million US$), 2024 - 2032
  • Figure-91: Terumo Corporation - Global Revenue (Million US$), 2019 - 2023
  • Figure-92: Terumo Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032

List of Tables

  • Table-01: Global - Cardiovascular Surgical Devices Market Share by Product Type (Percent), 2019 - 2023
  • Table-02: Global - Forecast for Cardiovascular Surgical Devices Market Share by Product Type (Percent), 2024 - 2032
  • Table-03: Global - Cardiovascular Surgical Devices Market Share by Application (Percent), 2019 - 2023
  • Table-04: Global - Forecast for Cardiovascular Surgical Devices Market Share by Application (Percent), 2024 - 2032
  • Table-05: Global - Cardiovascular Surgical Devices Market Share by End User (Percent), 2019 - 2023
  • Table-06: Global - Forecast for Cardiovascular Surgical Devices Market Share by End User (Percent), 2024 - 2032
  • Table-07: Global - Cardiovascular Surgical Devices Market Share by Countries (Percent), 2019 - 2023
  • Table-08: Global - Forecast for Cardiovascular Surgical Devices Market Share by Countries (Percent), 2024 - 2032